Frontiers in Aging Neuroscience
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. It is the cause of 60–70% of cases of dementia. In this study, Dr. Lau and coworkers discovered a translational biomarker in preclinical stages of the AD.
Read more at Frontiers in Aging Neuroscience:
https://www.frontiersin.org/articles/10.3389/fnagi.2019.00039/full
22 Mar 2019
Soft Matter and Biophysics
Soft Matter and Biophysics